Cardinal Health Is Second Infusion Pump Maker To Be Hit By An FDA Seizure
This article was originally published in The Gray Sheet
Executive Summary
FDA's seizure of infusion pumps made by Cardinal Health was the agency's second such enforcement action against an infusion pump manufacturer in less than a year
You may also be interested in...
FDA To Impose New Pre-market Requirements On Infusion Pump Makers
To address widespread safety issues, FDA plans to put in place new requirements for external infusion pump 510(k) submissions, including asking device makers to provide an "assurance case" to document and support safety design specifications
FDA To Impose New Pre-market Requirements On Infusion Pump Makers
To address widespread safety issues, FDA plans to put in place new requirements for external infusion pump 510(k) submissions, including asking device makers to provide an "assurance case" to document and support safety design specifications
CareFusion Mulls Relaunch Of Alaris SE After FDA Lifts Injunction
CareFusion said it is evaluating a timeline for re-introducing its Alaris SE infusion pump after FDA recently informed the firm it has lifted an injunction barring sales of the devices in the U.S